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The current cancer care system must be improved if we are to have in-depth knowledge
about breast cancer patients’ experiences throughout all the stages of their disease.
Aim
This study seeks to describe breast cancer patients’ experience over the course of the vari-
ous stages of illness by means of a journey model.
Methods
This is a qualitative descriptive study. Individual, semi-structured interviews will be adminis-
tered to women with breast cancer and breast cancer survivors. Patients will be recruited
from nine large hospitals in Spain and intentional sampling will be used. Data will be col-
lected by means of a semi-structured interview that was elaborated with the help of medical
oncologists, nurses, and psycho-oncologists. Data will be processed adopting a thematic
analysis approach.
Discussion
The outcomes of this study will afford new insights into breast cancer patients’ experiences,
providing guidance to improve the care given to these individuals. This protocol aims to
describe the journey of patients with breast cancer through the healthcare system to estab-
lish baseline data that will serve as the basis for the development and implementation of a
patient-centered, evidence-based clinical pathway.
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Introduction
The number of cases of cancer continues to grow around the world, thanks to populational
screening and the progress and extension of diagnostic testing, as well as to the increase in the
risk factors we are currently exposed to, in particular, aging [1]. Breast cancer (BC) is currently
the second most common cancer overall and the leading cancer in women, with more than 2
million new cases diagnosed in 2018 [2]. It is estimated that in Spain, the year 2020 will witness
almost 33 thousand new cases in women [3]. Nevertheless, due to therapeutic advances and
early diagnosis, survival and mortality have improved in recent years [4].
Breast cancer patients tend to be diagnosed when they are relatively young, around 55 years
of age [5]. These individuals, given treatment side effects and sequelae, are three times more
likely to experience physical symptoms and psychological disorders than patients with other
kinds of tumors [6, 7]. Once diagnosed, they go through different phases. If we are to support
and accompany them in this process, we must have a profound understanding of their experi-
ences. As put forth by Hall et al. [8], “patient voice” is a term that has become more common
in healthcare contexts and serves to describe the whole of the patient’s experiences, encom-
passing thoughts, emotions, feelings, worries, and concerns, amongst others. Thus, we can
ascertain how cancer affects patients—physically, emotionally, cognitively, socially, and spiri-
tually. This “patient voice” can be depicted as a journey, an experiential map of the different
stages of disease subjects go through [9]. Like all cancers, the person receives a diagnosis, prog-
nosis, and treatment; they recover, and, in the event of relapse, develop metastases. This care
continuum is what is known as a “cancer journey”.
To a greater or lesser extent, each cancer diagnosis conceals the story of a life or existential
crisis [10] that necessitates a major effort to adjust and adapt that will entail psychological
repercussions for the individual [11]. This diagnosis is generally unexpected and psychological
distress ensues in practically all patients, including feelings of uncertainty, disbelief, hopeless-
ness, vulnerability, anger, fear, anxiety, and sadness [12, 13]. All of this implies a drastic change
that, on occasion, compels the person to assume a new identity as a cancer patient who must
also confront employment, economic, and psychosocial effects. Their lifestyle and self-percep-
tion change and their families are also affected [10]. The most common physical and psycho-
logical symptoms in patients during and following breast cancer treatment include fatigue,
pain, and depression [14–17], in addition to fear of relapse [18] and of treatment side effects
[19]. These symptoms undermine their psychological wellbeing and quality of life after diagno-
sis, when initiating therapy, and following surgery or systemic treatment [15].
Qualitative studies are gaining relevance to better comprehend specific aspects, such as willing-
ness (or not) to participate in these studies [20]; breast cancer symptom recognition and evalua-
tion [21, 22]; the importance of social support [23] or physical exercise [24] on survival and
quality of life of these individuals. Nevertheless, to the best of our knowledge, there are no studies
that analyze patients’ experience from diagnosis to treatment and follow up. Therefore, the aim of
this study is to portray breast cancer patients’ experiences as they travel through all the stages of
the disease. Although the patient’s role in the course of the disease and in medical decision making
is increasingly important, little research has focused on the patient´s experiences [25, 26].
A breast cancer patient journey map will enable health care professionals to gain first-hand
knowledge about their patients’ personal experiences, enhance communication and under-
standing in the physician-patient relationship, thereby creating a better, more person-centered
system. Moreover, the journey information may aid in redesigning the service, improving
quality, planning changes more effectively, and in shifting the focus of care toward activities
most valued by the patient [27]. We hope that this protocol will encourage researchers to create
more patient journey maps.
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Methods
Study design
In this study, a qualitative method will be used to explore the pathway of standard care for
women with breast cancer and to develop a schematic map of their journey process based on
their experiences [27]. As Sandelowski comments [28], by means of this approach, the experi-
ence is detailed from the person’s perspective and, following analysis, an in-depth description
of patient experiences is presented. Healthcare Process Mapping is an important new form of
clinical audit that examines how we organize the patient´s journey, using the patient’s perspec-
tive to identify problems and suggest improvements [29]. It allows us to understand the
patient’s experience by separating the management of a specific condition or treatment into a
series of consecutive events or steps (e.g., diagnostic procedures, therapeutic interventions,
staff interactions, activities). Process Mapping has shown clinical benefit across a variety of
specialties, multidisciplinary teams, and healthcare systems [27].
This study will be performed in accordance with the ethical standards of the Declaration of
Helsinki and its later amendments. This study was approved by the Research Ethics Commit-
tee of University of Barcelona (Institutional Review Board: IRB00003099) and supported by
the Bioethic Group of the Spanish Society of Medical Oncology (SEOM) 2018 grant.
The study will be conducted in nine large hospitals in six geographical areas in Spain. Each
study site has more than 100 beds and reference and tertiary oncology services.
Participants
The presence of women with breast cancer and breast cancer survivors with a team of medical
oncologists, oncology nurses and psycho-oncologists as consultants is anticipated. Study
participants will comprise women with breast cancer who go to the sites for follow-up between
December 2019 and January 2021. Inclusion criteria will be having been diagnosed with a
histologically confirmed adenocarcinoma of the breast in the last 5 years and being over the
age of 18 years. Those who are not in good physical/ mental state during the study period will
be excluded. Medical oncologists and nurses who work at the centers will help to identify
patients who meet the inclusion criteria, develop the written material, and interpret and clini-
cally contextualize the results of the interview, but will not actively participate in the
interviews.
An intentional sampling procedure will be used to recruit participants for the study based
on age, marital status, level of education, employment status, having children, as well as clinical
data, such as the stage of the disease and type of cancer treatment received. Therefore, patients
will be interviewed with different cancer stages and who find themselves at different moments
in their journey. The aim is to access the various experiences and promote transferability of
the findings. Participation will be voluntary, and all participants will be asked about their own
experiences.
Data collection
A bibliographic search will be conducted on Medline and Scopus Electronic Database for the
terms “breast cancer”, “wellbeing”, “mental health”, and “patient voice”, since 2015, with the
aim of delving into the theoretical and conceptual framework of the topic. Based on this
review, an interview guide will be created for data collection. A pilot test will be conducted in a
public university hospital to evaluate the acceptability and ease of the interview process. The
interview guide will be reviewed by two oncologists, three nurses (a day hospital cancer nurse,
a case manager nurse who liaises with the different services, and the nurse in charge of
PLOS ONE Breast cancer patient journey protocol
PLOS ONE | https://doi.org/10.1371/journal.pone.0244355 December 21, 2020 3 / 8
explaining postoperative care and treatment), as well as two psycho-oncologists to make the
necessary modifications prior to conducting the final interviews included in the analysis
(S1 File). The interview will cover four main blocks. First, patients’ sociodemographic
and medical information will be gathered. Second, daily activities, family, and support network
will be discussed. Third, participants will be asked about their overall perception of breast
cancer and their coping mechanisms. Finally, physical, emotional, cognitive, spiritual, and
medical aspects related to diagnosis, treatment, and side effects will be probed. Additionally,
patients will be encouraged to express their thoughts should they have more to say about the
subject.
All the interviews will be performed by the fist author of the manuscript in a private space
on the hospital grounds; if that is not possible, it will be conducted online. All the interviews
will be recorded with the consent of the study subjects. Relevant notes will also be taken during
the interview to document key issues and observations. The interviews will continue until the
point of relative saturation is reached as regards the issues being discussed, lasting between 60
and 75 minutes. In general, a single interview will be carried out, although the contact will be
saved, in case clarification is need for any aspect of the interview that had not been clearly
recorded. To avoid bias arising from the timing of the interview, patients are three different
time points will be represented: 1) after surgery, 2) during systemic treatment, and 3) at some
point during the year following treatment completion.
Data analysis
The data will undergo a qualitative content analysis. To assure trustworthiness, the analysis
will be based on the system put forth by Graneheim and Lundman [30]. First, transcribing the
interviews for analysis and reading them over several times so as to be familiar with the mate-
rial and gain a broad understanding of the experiences of patients with breast cancer. This will
be followed by a more deductive analysis of those aspects of patient´s experiences that are of
primary interest to the research team (i.e., knowledge and experience of their cancer and treat-
ment, risk awareness, experiences of cancer care services, overall health status, satisfaction
with cancer services, and perceived health care needs). Next, it will continue dividing the text
into different content areas; obtaining units of meaning and putting them into each content
area; extracting and adding a unit of meaning code; categorizing codes in terms of differences
and similarities, and creating themes to link underlying meanings in the categories. Key
aspects of cancer-patient´s knowledge and experience will be identified. A subject analysis
approach will be used to categorize the codes by means of several iteration. This will be done
by the authors of the manuscript. Team members will review the data and triangulate the out-
comes between two sources of data: qualitative data from the interview and non-modifiable
information, such as sociodemographic (i.e., age, marital status, having children) and clinical
(i.e., cancer stage, and surgery type) data. The categories will be discussed at length and vali-
dated by all the authors to guarantee that the issues put forth are cogent.
Informed consent materials
All participants will receive a written informed consent form that they will sign prior to com-
mencing with the interviews and after receiving information about the study. Said consent
form will guarantee that they have received clear and sufficient information about the study;
that their decision is voluntary, and that they understand that they can withdraw at any time.
Likewise, they consent to the collection, analysis, and release of the information they share, to
recording of the interview, and to the use of their own words in future publications.
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Discussion
Contribution
So far as we are aware, this study will be the first qualitative research that will describe the
experience of patients with breast cancer throughout the various stages of the disease using a
journey model.
The knowledge garnered will enable us to comprehend breast cancer patients’ experiences
in detail, as well as the reasons for them. Furthermore, having first-person information from
these patients will promote greater understanding of their situation, their emotional state, and
the empathy of all the stakeholders, supporting sufferers and their families in receiving holistic
cancer care. In addition, this information is subject to being used at a micro level (for instance,
giving knowledge to healthcare professionals so that they can better understand and commu-
nicate with their patients, or shedding more light on key aspects of breast cancer patients’
experiences, such as the impact of diagnosis, questioning their own identity and femininity,
their approach to family communication–especially between mother and children-, repercus-
sions for their partner and in the workplace, their feelings and thoughts about the treatment,
or the significance they attached to the disease and the personal changes it brings), as well as at
a macro level (for example, redesigning care or integrating specific services provided by the
healthcare system) to enhance these women’s experiences. In this way, the current paradigm
that advocates for a patient-based healthcare system will continue to be fostered.
This protocol offers a clear methodological guide for patients’ journey in healthcare. Jour-
ney maps, which originate in the field of service design [31], have been used in various areas to
illustrate complex processes or interactions that would otherwise be difficult to apprehend. In
the field of healthcare, journey maps can be used to depict service from the perspective of dif-
ferent stakeholders, like the patient, giving them a central role [32]. Healthcare process map-
ping is considered a new and important form of clinical auditing that examines how the
patient journey is managed [27, 33]. This protocol seeks to encourage the realization of Patient
Journeys, a highly useful tool that is still uncommon in investigation, giving researchers greater
confidence, as well as improving study reliability.
There is a clear need to prepare patients facing this diagnosis for prolonged, multimodal
treatment (surgery, chemotherapy, hormonotherapy, radiotherapy) and to confront physical
and psychological sequelae, in addition to the fear surrounding an uncertain prognosis. It’s
important to manage their expectations; similarly, identifying and addressing the issues that
arise at different time points during treatment for their disease could improve the patient’s
experience.
Study limitations
This study will be conducted with Spanish participants, which is why certain aspects cannot
reflect the experiences of breast cancer patients from other countries, both because of the par-
ticularities of the Spanish healthcare system and Spanish culture. Likewise, the data attained
will be specific to women with breast cancer, which can scarcely be extrapolated to individuals
with other cancers. Finally, the findings do not reflect men’s experiences with breast cancer
and research with this group would enrich the field further.
Supporting information
S1 File. This is the semi-structured interview guide to breast cancer patients/survivors.
(DOCX)
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Project administration: Laura Ciria-Suarez, Paula Jiménez-Fonseca, Caterina Calderon.
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